Fundraising Fox

CND Life Sciences

Scottsdale, US · Founded 2017 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

CND Life Sciences was founded in 2017 by Todd Levine.

TLTodd Levine
Todd LevineinFounder
RJRichard J. Morello
Richard J. MorelloExecutive
PHPeter Harris
Peter HarrisinExecutive
CG
Christopher GibbonsNamed on SEC filing

Board

JS
Jack SeaverBoard director
EC
Enrique CarrazanaBoard director
RF
Roy FreemanBoard director

Investors · 2

BlueStone Venture PartnersTucson · $250K – $1M
Top Corner CapitalBurlingame

Reported raises · per SEC filings

Form D private placements

$30M disclosed across 7 rounds · 2021–2026

▶$6.3MraisedAug 2026 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J. MorelloExecutive Officer, Director
  • Todd LevineExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Christopher GibbonsDirector
  • Jack SeaverDirector
Offering amount
$6.3M
Amount sold
$6.3M
Minimum investment
$25K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedMay 2025 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard J. MorelloExecutive Officer, Director
  • Todd LevineExecutive Officer, Director
  • Jack SeaverDirector
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Christopher GibbonsDirector
Offering amount
$9M
Amount sold
$8.6M
Minimum investment
$25K
Sales commissions
$36K
Placement agents
Finalis Securities
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2024 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HarrisDirector
  • Richard J. MorelloExecutive Officer, Director
  • Enrique CarrazanaDirector
  • Todd LevineExecutive Officer, Director
Offering amount
$6M
Amount sold
$2M
Minimum investment
$25K
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Enrique CarrazanaDirector
  • Richard J. MorelloExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Todd LevineDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedMar 2023 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd LevineExecutive Officer, Director
  • Richard J. MorelloExecutive Officer, Director
  • Peter HarrisExecutive Officer, Director
  • Enrique CarrazanaDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedNov 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HarrisDirector
  • Enrique CarrazanaDirector
  • Todd LevineDirector
  • Richard J. MorelloExecutive Officer, Director
  • Roy FreemanDirector
Offering amount
$5M
Amount sold
$4.2M
Minimum investment
$50K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2021 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roy FreemanDirector
  • Todd LevineDirector
  • Peter HarrisDirector
  • Richard J. MorelloExecutive Officer, Director
  • Christopher GibbonsDirector
Offering amount
$2.9M
Amount sold
$2.9M
Minimum investment
$50K
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Medscape129 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with CND Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2.4M
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2.4M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

VC funding deals: CND Life Sciences, JIJ, Actualyze AI - InfotechLeadinfotechlead.com · Aug 2026CND Life Sciences Secures Growth Financing to Scale Syn-One Neurodiagnostics Platform - TipRanks.comtipranks.com · Aug 2026CND Life Sciences Announces Growth Financing Led by S-Curve Partners to Accelerate Expansion of the Syn-One Test® Platform and the Company's Precision Neurology Missionstreetinsider.com · Aug 2026CND Life Sciences Secures Growth Financing to Expand Syn-One Test Platform | citybizcitybiz.co · Aug 2026CND Life Sciences Closes Growth Fundingfinsmes.com · Aug 2026CND Life Sciences raises $13.5M to expand neurodegenerative tests - Phoenix Business Journalbizjournals.com · May 2025

Frequently asked questions

Who founded CND Life Sciences?
CND Life Sciences was founded by Todd Levine in 2017.
Who are CND Life Sciences's investors?
CND Life Sciences's investors include BlueStone Venture Partners, Top Corner Capital.
How much funding has CND Life Sciences raised?
CND Life Sciences has disclosed $30M raised across 7 rounds.
Where is CND Life Sciences headquartered?
CND Life Sciences is headquartered in Scottsdale, US.